Moxibustion for the treatment of chemotherapy-induced leukopenia: a systematic review of randomized clinical trials

Supportive Care in Cancer

Volumn 23, Issue 6, 2015, Pages 1819-1826

  Choi, Tae Young ^a   Lee, Myeong Soo ^a   Ernst, Edzard ^b  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

^b UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

Leukopenia; Low white blood cell (WBC) count; Moxibustion; Randomized controlled trials (RCTs); Systematic review

Indexed keywords

ANTINEOPLASTIC AGENT;

CHEMICALLY INDUCED; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMAN; LEUKOCYTE COUNT; LEUKOPENIA; MALE; MIDDLE AGED; MOXIBUSTION; MULTIMODALITY CANCER THERAPY; NEOPLASMS; PROCEDURES; QUALITY OF LIFE;

ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; LEUKOCYTE COUNT; LEUKOPENIA; MALE; MIDDLE AGED; MOXIBUSTION; NEOPLASMS; QUALITY OF LIFE;

EID: 84933568330     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-014-2530-7     Document Type: Article

References (38)

1. World Health Organization (2014) Cancer. http://www.who.int/mediacentre/factsheets/fs297/en/ Accessed 10 June 2014
2. Yamanaka T, Matsumoto S, Teramukai S, Ishiwata R, Nagai Y, Fukushima M (2007) Predictive value of chemotherapy-induced neutropenia for the efficacy of oral fluoropyrimidine S-1 in advanced gastric carcinoma. Br J Cancer 97:37–42
3. Liu W, Zhang CC, Li K (2013) Prognostic value of chemotherapy-induced leukopenia in small-cell lung cancer. Cancer Biol Med 10:92–98
4. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad I, Rolston KV, Young JA, Wingard JR, Infectious Diseases Society of America (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52:56–93
5. Clark OA, Lyman GH, Castro AA, Clark LG, Djulbegovic B (2005) Colony-stimulating factors for chemotherapy-induced febrile neutropenia: a meta-analysis of randomized controlled trials. J Clin Oncol 23:4198–4214
6. Dale DC (2009) Advances in the treatment of neutropenia. Curr Opin Support Palliat Care 3:207–212
7. Aapro MS, Bohlius J, Cameron DA, Dal Lago L, Donnelly JP, Kearney N, Lyman GH, Pettengell R, Tjan-Heijnen VC, Walewski J, Weber DC, Zielinski C, European Organisation for Research and Treatment of Cancer (2011) 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. Eur J Cancer 47:8–32
8. Patterson RE, Neuhouser ML, Hedderson MM, Schwartz SM, Standish LJ, Bowen DJ, Marshall LM (2002) Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs. J Altern Complement Med 8:477–485
9. World Health Organization (2007) WHO international standard terminologies on traditional medicine in the western pacific region. World Health Organization, Western Pacific Region, Manila, Philippines
10. World Health Organization Western Pacific Region (2007) WHO international standard terminologies on traditional medicine in the western pacific region. Manila
11. Deng H, Shen X (2013) The mechanism of moxibustion: ancient theory and modern research. Evid Based Complement Alternat Med 2013:379291
12. Yang HQ, Liu XG, Yang X, Chen T, Yu SG (2013) Effect of different types of moxibustion intervention on expression of inflammatory cytokines IL-1 and TNF-alpha in rabbits with rheumatoid arthritis. Zhen Ci Yan Jiu 38:134–139
13. Zhang JL, Li SS, Luo WH, Zhang DF, Shu RG (2008) Research of moxibustion therapy for cancer: a review. Jiangxi J Tradit Chin Med 39:59–61
14. Lee MS, Choi TY, Park JE, Lee SS, Ernst E (2010) Moxibustion for cancer care: a systematic review and meta-analysis. BMC Cancer 10:130
15. Pei J, Yu YM, Wei H, Fang ZQ, Guan DY, Yu QW (2007) Experimental research on moxibustion in modulating tumor immunosuppression. Shanghai J Tradit Chin Med 41:1–4
16. Cui J, Yan J (2007) Effect of moxibustion or acupuncture at Geshu acupoint on the granulocyte-macrophage colony stimulating factor of cyclophosphamide induced leukopenic rats. J Clin Rehabil Tissue Eng Res 11:5473–5476
17. Yang HY, Hu ZC (2010) Biophysical characteristics of moxibustion. World J Acupunct Moxibustion 20(27–31):37
18. Lu J, Zhang HL, Yin ZZ, Tu Y, Li ZG, Zhao BX, Guo JY (2012) Moxibustion attenuates inflammatory response to chronic exhaustive exercise in rats. Int J Sports Med 33:580–585
19. Zhao XX, Hang XM, Wang HP, Lu M, Yu TK (2011) Effect of acupuncture-moxibustion on bone marrow suppression and leukocytes after chemotherapy. J Acupunct Tuina Sci 9:331–335
20. Li Y, Li P (2010) The research progress of acupuncture in the treatment of leukopenia after radiotherapy and chemotherapy. Gansu J Tradit Chin Med 23:71–73
21. Lee MS, Kim T-H, Ernst E (2012) Is acupuncture or moxibustion better than a sham or placebo-treatment? In: Cho WCS (ed) Acupuncture and moxibustion as an evidence-based therapy for cancer. Springer Netherlands, pp. 249-264
22. Choi T-Y, Lee M, Ernst E (2012) An overview of acupuncture and moxibustion for cancer care. In: Cho WCS (ed) Acupuncture and Moxibustion as an evidence-based therapy for cancer. Springer Netherlands, pp. 1-18
23. Zhang HW, Lin ZX, Cheung F, Cho WCS, Tang JL (2013) Moxibustion for alleviating side effects of chemotherapy or radiotherapy in cancer patients (Protocol). Cochrane Database Syst Rev. doi:10.1002/14651858.CD010559
24. Lu W, Hu D, Dean-Clower E, Doherty-Gilman A, Legedza AT, Lee H, Matulonis U, Rosenthal DS (2007) Acupuncture for chemotherapy-induced leukopenia: exploratory meta-analysis of randomized controlled trials. J Soc Integr Oncol 5:1–10
25. Higgins JPT, Altman DG, Sterne JAC (2011) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (eds) Cochrane handbook for systematic reviews of interventions version 510. The Cochrane Collaboration,http://www.cochrane-handbook.org, Accessed 28 May 2014
26. Wu YT, Wu JY, Yue HP (2013) Observation on thermal moxibustion on myelosuppression induced by chemotherapy in patients with malignant tumor. Liaoning J Tradit Chin Med 40:2120–2121
27. Shao KW, Kong YM (2012) Clinical study on herbs-partitioned moxibustion treatment of after chemotherapy with leukopenia in 82 cases. Hunan J Tradit Chin Med 28:86–87
28. Li PH (2012) Clinical study on ginger moxibustion for the treatment of leukopenia after chemotherapy of cancer. China J Chin Med 27:1244–1245
29. Zhao XX, Lu M, Zhu X, Gao P, Li YL, Wang XM, Ma DY, Guo XH, Tong BY, Yang XL, Du WW, Zhou SF, Liu HM, Ran PF, Lu XR (2007) Multi-central clinical evaluation of ginger-partitioned moxibustion for treatment of leukopenia induced by chemotherapy. Chin Acupunct Moxibustion 27:715–720
30. Zhang Y, Luo YX, Caui XP, Hu H (2013) Clinical observation on the treatment of leukocytopenia after chemotherapy in 45 patients with malignant tumor receiving herbs-partitioned moxibustion. Pharm Clin Chin Mater Medica 4:42–43
31. Liang JJ, Luo GY, Du ZP (2012) Clinical observation on herbs-partitioned moxibustion prevention for gastrointestinal cancer with cause chemotherapy of bone marrow suppression. J Emerg Tradit Chin Med 21:1330–1331
32. Vickers A, Goyal N, Harland R, Rees R (1998) Do certain countries produce only positive results? A systematic review of controlled trials. Control Clin Trials 19:159–166
33. Schulz KF (2001) Assessing allocation concealment and blinding in randomised controlled trials: why bother? Evid Based Nurs 4:4–6
34. Zhao B, Wang X, Lin Z, Liu R, Lao L (2006) A novel sham moxibustion device: a randomized, placebo-controlled trial. Complement Ther Med 14:53–60
35. Park JE, Lee SS, Lee MS, Choi SM, Ernst E (2010) Adverse events of moxibustion: a systematic review. Complement Ther Med 18:215–223
36. Moor A, McQuay H (2006) Bandolier’s little book of making sense of the medical evidence. Oxford University Press, Oxford
37. Schulz KF, Altman DG, Moher D, CONSORT Group (2011) CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Int J Surg 9:672–677
38. MacPherson H, Altman DG, Hammerschlag R, Youping L, Taixiang W, White A, Moher D, STRICTA Revision Group (2010) Revised STandards for reporting interventions in clinical trials of acupuncture (STRICTA): extending the CONSORT statement. J Evid Based Med 3:140–155